Increasing insulin secretion (represented by increasing C-peptide levels) in response to an antidiabetic treatment might indicate two mechanisms: stronger compensation of growing insulin resistance or restoration of initially impaired insulin secretion capacity. Here, INS is linked to Insulin resistance.